Showing results (61-70 of 104) with videos related to
Sort By:
Pageof 11
Cells|March 25, 2022
Batch Effects during Human Bone Marrow Stromal Cell Propagation Prevail Donor Variation and Culture Duration: Impact on Genotype, Phenotype and FunctionGabriele Brachtl, Rodolphe Poupardin, Sarah Hochmann, et al.Journal of Extracellular Vesicles|September 23, 2025
Selective EV Protein Sorting and Pathway Perturbation in AML Upon Synergistic FLT3 and Hedgehog Pathway InhibitionConstantin Blöchl, Gabriele Blümel, Martin Wolf, et al.International Journal of Molecular Sciences|January 21, 2023
Chondrocyte Isolation from Loose Bodies-An Option for Reducing Donor Site Morbidity for Autologous Chondrocyte ImplantationMartin Textor, Arnd Hoburg, Rex Lehnigk, et al.Scientific Reports|August 30, 2018
Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancerSarah Hochmann, Michaela Mittermeir, Radmila Santic, et al.Pediatric Transplantation|December 14, 2011
Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantationMarc Ansari, Dirk Strunk, Katharina Schallmoser, et al.Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|August 18, 2012
Tri-lineage potential of intraoral tissue-derived mesenchymal stromal cellsBirgit Lohberger, Michael Payer, Beate Rinner, et al.Scientific Reports|March 16, 2021
Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expressionMarie-Theresa Weickert, Judith S Hecker, Michèle C Buck, et al.Cardiovascular Diabetology|May 19, 2018
Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trialNorbert J Tripolt, Felix Aberer, Regina Riedl, et al.International Journal of Molecular Sciences|March 29, 2023
A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis BullosaJanine Zwicklhuber, Thomas Kocher, Bernadette Liemberger, et al.Theranostics|March 7, 2018
Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal CellsMichaela Oeller, Sandra Laner-Plamberger, Sarah Hochmann, et al.Pageof 11